Aptamer-sirna Chimera
Aptamer-sirna Chimera - Related Videos
02:30
siRNA - Small Interfering RNAs
0 Views •
2020
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements. In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
08:09
Mapping the Binding Site of an Aptamer on ATP Using MicroScale Thermophoresis
0 Views •
Cited by 12 •
2017
MicroScale Thermophoresis (MST) is a sensitive technology to characterize aptamer-target interactions. This manuscript describes an MST protocol to characterize aptamer-small molecule interactions.
13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
0 Views •
Cited by 36 •
2011
Several 2’-Fluoro RNA aptamers against HIV-1Ba-L gp120 with nanomole affinity are isolated from a RNA library by in vitro SELEX procedure. A new dual inhibitory function anti-gp120 aptamer-siRNA chimera is created and shows considerable promise for systemic anti-HIV therapy.
03:04
siRNA Encapsulation into Exosomes Using Electroporation: An Electric Pulse Based Technique to Load siRNA into Exosomes
0 Views •
2023
This video describes an electroporation-based method for encapsulating siRNA into exosomes. The siRNA-loaded exosomes can then be used for therapeutic applications.
05:15
An Aptamer-based Sensor for Unchelated Gadolinium(III)
0 Views •
2017
The use of polydeoxynucleotide (44-mer aptamer) molecules for sensing unchelated gadolinium(III) ion in an aqueous solution is described. The presence of the ion is detected via an increase in the fluorescence emission of the sensor.
FAQs
The aptamer portion provides molecular recognition by selectively binding a receptor displayed on the target cell surface. This interaction can promote receptor-mediated internalization, concentrating the construct within cells that carry the relevant receptor rather than distributing it indiscriminately. In immunology and infection studies, receptor choice therefore influences which immune or infected-cell populations are exposed to gene-silencing activity.
Following internalization, the siRNA must become available for incorporation into the RNA-induced silencing complex, or RISC. Once loaded, the complex uses sequence complementarity to recognize the corresponding messenger RNA and promote its degradation. This step connects cell targeting with functional gene suppression, allowing researchers to associate receptor engagement with reduced expression of a selected gene.
The aptamer can bias delivery toward cells bearing a selected surface receptor, while the siRNA supplies sequence-specific gene silencing after entry. Together, these features offer two levels of selectivity: cellular recognition and complementary messenger-RNA targeting. In RNA therapeutic research, this arrangement may reduce unintended effects compared with exposing non-target cells to the same silencing sequence.
The silencing sequence determines which complementary messenger RNA is targeted, so the construct can be designed for investigations of host genes or pathogen-associated genes. Host-directed use can examine immune regulation, whereas pathogen-focused use can probe infectious disease mechanisms. This distinction helps researchers study whether changing host responses or suppressing pathogen-related functions produces the desired biological effect.
Evaluation can follow the construct from receptor binding through cellular internalization, siRNA release, RISC incorporation, and complementary messenger-RNA degradation. Each stage provides a distinct point for examining whether targeting leads to intracellular gene silencing. Measuring these linked events helps separate inadequate receptor recognition or entry from failure of the downstream RNA-interference mechanism.
The strategy is relevant when investigators need to suppress a defined gene in selected cells while studying immune regulation or infectious disease mechanisms. It can support precision antiviral or antimicrobial investigations by directing RNA-mediated silencing toward cells recognized through a surface receptor. The resulting data can clarify how particular host or pathogen-associated genes contribute to disease-related processes.